Article Versions Notes

Mazzotta V, Piselli P, Cozzi Lepri A, Matusali G, Cimini E, Esvan R, Colavita F, Gagliardini R, Notari S, Oliva A, et al. Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route. Vaccines. 2025; 13(1):32. https://doi.org/10.3390/vaccines13010032

Mazzotta, Valentina, Pierluca Piselli, Alessandro Cozzi Lepri, Giulia Matusali, Eleonora Cimini, Rozenn Esvan, Francesca Colavita, Roberta Gagliardini, Stefania Notari, Alessandra Oliva, and et al. 2025. "Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route" Vaccines 13, no. 1: 32. https://doi.org/10.3390/vaccines13010032

Mazzotta, V., Piselli, P., Cozzi Lepri, A., Matusali, G., Cimini, E., Esvan, R., Colavita, F., Gagliardini, R., Notari, S., Oliva, A., Meschi, S., Casetti, R., Micheli, G., Bordi, L., Giacinta, A., Grassi, G., Gebremeskel Tekle, S., Cimaglia, C., Paulicelli, J., ... Antinori, A., on behalf of the MPOX Vaccine Lazio Study Group. (2025). Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route. Vaccines, 13(1), 32. https://doi.org/10.3390/vaccines13010032